United Therapeutic
(UTHR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 240,900 | 727,300 | 595,200 | 355,900 | 239,900 |
| Depreciation Amortization | 13,300 | 51,300 | 38,100 | 25,200 | 12,500 |
| Accounts receivable | 85,900 | -21,700 | -33,000 | 25,300 | 28,100 |
| Accounts payable and accrued liabilities | 2,800 | 44,500 | 35,400 | 13,100 | -10,800 |
| Other Working Capital | 127,200 | -141,200 | -53,400 | -46,100 | 67,900 |
| Other Operating Activity | -95,300 | 142,300 | 92,000 | 42,300 | -48,900 |
| Operating Cash Flow | $374,800 | $802,500 | $674,300 | $415,700 | $288,700 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -889,500 | -1,706,300 | -1,275,800 | -1,008,100 | -477,600 |
| PPE Investments | -41,300 | -138,800 | -99,300 | -30,500 | -13,500 |
| Sale Of Investment | 709,700 | 1,030,100 | 752,900 | 510,400 | 131,900 |
| Other Investing Activity | 0 | 3,500 | 0 | 0 | 0 |
| Investing Cash Flow | $-221,100 | $-811,500 | $-622,200 | $-528,200 | $-359,200 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 800,000 | 800,000 | 800,000 | 800,000 |
| Common Stock Issued | 64,800 | 94,300 | 38,800 | 31,500 | 7,600 |
| Common Stock Repurchased | -13,500 | -11,400 | -11,400 | -11,100 | -11,100 |
| Other Financing Activity | -2,700 | -807,500 | -807,500 | -807,500 | -807,500 |
| Financing Cash Flow | $48,600 | $75,400 | $19,900 | $12,900 | $-11,000 |
| Beginning Cash Position | 961,200 | 894,800 | 894,800 | 894,800 | 894,800 |
| End Cash Position | 1,163,500 | 961,200 | 966,800 | 795,200 | 813,300 |
| Net Cash Flow | $202,300 | $66,400 | $72,000 | $-99,600 | $-81,500 |
| Free Cash Flow | |||||
| Operating Cash Flow | 374,800 | 802,500 | 674,300 | 415,700 | 288,700 |
| Capital Expenditure | -41,300 | -138,800 | -99,300 | -30,500 | -13,500 |
| Free Cash Flow | 333,500 | 663,700 | 575,000 | 385,200 | 275,200 |